Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04285398 · ClinicalTrials.gov registry record · NA

Prospective Natural History Study of Retinitis Pigmentosa

A NA study of Retinitis Pigmentosa, sponsored by SparingVision.

Active
Registry status
NA
Development phase
82
Enrollment target
2
Study locations

NCT04285398 is a NA study of Retinitis Pigmentosa that is active but no longer recruiting, run by SparingVision. The registered enrollment target is 82 participants, below the 259-participant average among 37 other Retinitis Pigmentosa trials with a reported enrollment target (68% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04285398, a NA study of Retinitis Pigmentosa, is active but no longer recruiting, sponsored by SparingVision.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
82 participants
Enrollment target
2
Study locations

Study Summary

This is natural history study of rods and cones degenerations in patients with Retinitis Pigmentosa (RP) caused by pathogenic mutations in RHO, PDE6a or PDE6b gene mutations.

Conditions Studied

Retinitis Pigmentosa

Interventions

  • OTHER Ophthalmic examinations
  • OTHER Mobility Test

Study Locations (2)

Pennsylvania

  • UPMC Eye Center - Pittsburgh

Other

  • CHNO XV-XX Paris - CIC 1423 - Paris

Trial Details

FieldValue
Enrollment Target 82 participants
Start Date 2020-02-12
Est. Completion 2026-06-30
Phase NA

Sponsor

SparingVision

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04285398

The ClinicalTrials.gov registry entry for NCT04285398 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 259-participant average among 37 other Retinitis Pigmentosa trials with a reported enrollment target (68% lower). The listed sponsor is SparingVision, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Retinitis Pigmentosa appearing as the primary indexed condition, and to 2 interventions - of which Ophthalmic examinations is the first listed.

NCT04285398 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Pennsylvania, Other.

Frequently Asked Questions

What is clinical trial NCT04285398 about?

NCT04285398 is a clinical study titled "Prospective Natural History Study of Retinitis Pigmentosa". This is natural history study of rods and cones degenerations in patients with Retinitis Pigmentosa (RP) caused by pathogenic mutations in RHO, PDE6a or PDE6b gene mutations.

What is the current status of trial NCT04285398?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 82 participants. The study started on 2020-02-12. Estimated completion is 2026-06-30.

What conditions does trial NCT04285398 study?

This clinical trial studies the following conditions: Retinitis Pigmentosa.

What interventions are being tested in trial NCT04285398?

The interventions under investigation include: Ophthalmic examinations (OTHER), Mobility Test (OTHER).

Who is sponsoring clinical trial NCT04285398?

This trial is sponsored by SparingVision, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04285398 being conducted?

This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Retinitis Pigmentosa

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Retinitis Pigmentosa

All registered trials for this condition

Pennsylvania

All trials with a study site in Pennsylvania

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.